Dr. Noalle Fellah is a Senior Scientist in the Crystallization Technology Lab (CTL) within Chemical Research and Development (CRD) at Pfizer, Inc. Noalle earned her PhD in Chemistry from New York University in 2021. Her current work focuses on the design of robust and scalable crystallization processes of Active Pharmaceutical Ingredients (APIs). Since joining Pfizer in 2021, Noalle has contributed to the development of late-stage programs and transferred processes from the pilot plant to the commercial scale. Noalle represents Pfizer in the ETC Consortium for co-processing platform technology and is a co-lead on industry-academic collaborations. Noalle’s scientific interests include particle engineering, crystal polymorphism and nano-confined crystallization.